|Moderator: Xu Jiajun, Deputy Director General, Foreign Talent Research Center, MOST|
|14:00-14:05||Remarks by LI Xin, Deputy Director General, Department of Foreign Expert Services, MOST|
|14:05-14:10||Remarks by LANG Lin, Deputy Director, Policy, Advocacy and Government Relations, China Country Office, Bill & Melinda Gates Foundation|
|Moderator: LI Xin, Deputy Director General, Department of Foreign Expert Services, MOST|
|14:10-14:30||Speech Topic: Brief Talk on Importance of Global Cooperation in Epidemic Prevention under the Influence of COVID-19.
Dominique Bertrand (France), President of French National Commission of Public Health
|14:30-14:50||Speech Topic: Study on Recombinant Vaccine against COVID-19 Based on New Adjuvants.
XIA Ningshao, Dean of School of Public Health, Xiamen University
|14:50-15:10||Speech Topic: Global Innovations in Manufacturing Technologies for Pandemic Vaccine Responses.
David K Robinson (the United States), Deputy Director, Vaccine Development and Surveillance, Bill & Melinda Gates Foundation
|15:10-15:30||Speech Topic: Evidence Demand for Vaccine Policy Making and Real-world Research.
AN Zhijie, Deputy Director of National Immunization Program, Chinese Center for Disease Control and Prevention
|15:30-15:50||Speech Topic: Global Cooperation in Prevention and Control of Major Infectious Diseases.
Mark Jit (the United Kingdom), Professor from London School of Hygiene & Tropical Medicine, University of London
|15:50-16:10||Speech Topic: “Made in China, Benefit the World” — GHDDI's Exploration in International Cooperation of Drug Research & Development.
LU Manchun, Chief Operating Officer of Global Health Drug Discovery Institute
|16:10-16:30||Speech Topic: Global Cooperation in Prevention and Control of Major Infectious Diseases.
Garcon Nathalie (Belgium), CEO of Bioaster
|16:30-16:40||Tea Break (Group Photo)|
|Moderator: XU Fujie, Deputy Director, Health, Innovation & Partnership, China Country Office, Bill & Melinda Gates Foundation|
Luca Falqui (Italy), Health Coordinator ICRC Regional Delegation for East Asia
Andrew Wong (the United States), General Manager, Shanghai Wotai Biotechnology Co., Ltd., a Walvax company
Jean-Marc Bovet (Switzerland), Chief Technical Officer of CF PharmaTech Inc.
FENG Luzhao, Executive Deputy Dean, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College
GAO Lei, Principal Investigator from the Institute of Pathogen Biology of Chinese Academy of Medical Sciences & Peking Union Medical College
DONG Jian (the United States), CEO of WuXi Vaccines and SVP of WuXi biologics